Objective. To determine the usefulness of reagent test strips for screening inflammatory synovial fluid (SF).
Analysis of synovial fluid (SF) is widely recognized as an important part of the diagnostic evaluation of patients with arthritis and joint effusion w1-4x. In particular, white blood cell (WBC) count in SF allows classification of SF as non-inflammatory or inflammatory w2, 3, 5, 6x. Prompt analysis is necessary because delay may lead to false negative results w7, 8x. When SF is removed from the joint, its WBC count decreases with time, and mildly inflammatory fluids with WBC counts up to 6000 cellsumm 3 can decrease to a non-inflammatory range of <2000 cellsumm 3 after only 6 h w8x. From a practical point of view, analysis within a short time can be difficult to obtain, and frequently SF analysis is not performed in primary care due to organizational problems. Consequently, we were interested in evaluating a simple method of quantification of WBC which would be available immediately at the point of care. Reagent strips originally designed for semiquantitation of leucocytes in urine have been used to measure leucocytes in various body fluids such as bronchoalveolar fluid and cerebrospinal fluid w9, 10x.
Our aim was to determine the performance of a commercially available reagent test strip in discriminating between inflammatory and non-inflammatory SF.
Patients and methods SF samples obtained from consecutive patients undergoing arthrocentesis at the Department of Rheumatology of Cochin Hospital and sent to the hospital laboratories during a 6-month period were analysed. The specimens had been collected in tubes containing EDTA. All samples were divided into two equal portions and examinations were made within 2 h of receipt of the SF sample. Using one portion of each specimen, the WBC count was measured by manual leucocyte counting using 0.3% saline as diluent. The other portion of each specimen was tested for the presence of leucocytes with commercial reagent strips (Multistix 8 SG, Bayer Diagnostics) that were originally designed to test urine for blood, pH, protein, nitrite and leucocytes. The reagent strip was dipped directly into the tube. The leucocyte pad changes colour according to the concentration of leucocytes. Two minutes after dipping, the sample is graded as negative, trace positive, + positive, ++ positive or +++ positive by comparison with a standard colour chart found on the container's label. The Multistix was considered positive if the leucocyte esterase pad was more than trace positive. This analysis was performed by an investigator unaware of the WBC count and of the diagnosis.
The sensitivity, specificity, positive predictive and negative predictive value and positive and negative likelihood ratio (LR+ and LR2) were estimated using the microscopic WBC count as the gold standard, and a graphic representation was presented as proposed by Brenner w11x. The cut-off for the WBC count (>2000 cellsumm 3 ) was used to classify patients as having inflammatory or non-inflammatory SF.
To assess the reproducibility of dipstick results, 50 consecutive SF samples were independently assessed by three readers and kappa coefficients were calculated.
Results
There was excellent agreement among the three readers, with a kappa coefficient of 0.97 (95% CI, 0.90-1.00; reader 1 vs reader 2), 0.96 (95% CI, 0.88-1.00; reader 2 vs reader 3) and 0.92 (95% CI, 0.81-1.00; reader 1 vs reader 3).
Two hundred and eight SF samples were obtained. According to the laboratory results, 78 of the 208 (37.5%) SF samples were inflammatory using a 2000 cellsumm 3 cut-off value. Diagnoses of the patients included, based on standard clinical, radiological and serological criteria, are presented in Table 1 . The results obtained with the reagent strips are shown in Fig. 1 .
Using the 2000 cellsumm 3 cut-off, inflammatory SF was correctly identified with the strip method in 60 of 78 cases. This yields a sensitivity of 76.9% (95% CI, 66.0-85.7%), a specificity of 86.9% (95% CI, 79.9-92.2%), a LR+ of 5.88 (95% CI, 3.71-9.31) and a LR2 of 0.27 (95% CI, 0.18-0.40). Nineteen false negatives were observed with the 2000 cellsumm 3 cut-off. The median WBC count for these patients was 3000 (range 2000-25 000 cellsumm 3 ) and only four of them had >6000 cellsumm 3 (6300, 15 000, 22 000 and 25 000 cellsumm 3 ). Among these false negatives, nine out of 18 had (3000 leucocytesumm 3 , and five of the nine remaining patients had >50% of lymphocytes (Table 2) .
Discussion
The data presented suggest that the reagent strip is a potentially useful test to discriminate inflammatory from non-inflammatory SF if a laboratory test is not available.
The false negative results observed in this study were predominantly in SF samples that had a high percentage of lymphocytes. Eleven of these patients with 18 false negative results had <2000 neutrophilsumm 3 and 13 out of 19 had <3000 neutrophilsumm 3 . These results are not surprising: the Multistix 8 reagent strip is designed for semi-quantitation of polymorphonuclear neutrophils (rather than leucocytes) by detecting leucocyte esterase enzyme activity. Leucocyte esterase enzyme activity is detectable in polymorphonuclear neutrophils and monocytes but not in lymphocytes w12x. SF testing at the site of primary care using reagent strips has the potential benefits of not requiring a laboratory and providing immediate results. These benefits may be offset by reduced accuracy compared with a laboratory result obtained in optimal conditions (i.e. short interval between joint aspiration and analysis, trained personnel, etc.). Furthermore, the results obtained are limited to the WBC count, which is only one element of a complete SF analysis that includes microbiological culture and crystal analysis.
However, in daily practice, the conditions in which WBC counts are made are probably not optimal. A survey of 42 hospitals revealed that in many laboratories the frequency of SF analysis is low, with a median of 1.5 per month and with numerous hospital laboratories performing one or less per month w13x. Consequently, the ability of some laboratories to perform routine SF analysis is doubtful. As an example in this study, the WBC count reported for a single fluid studied in 26 laboratories ranged from 2467 to 12 000 cellsumm 3 w13x. Secondly, in daily practice the time elapsed between joint aspiration and WBC count is frequently >3 h and can reach 12 h or more, particularly if the sample arrives at the laboratory during a weekend or off-hours, or if SF is shipped by the laboratory to a central facility. Consequently, WBC count tests performed in routine practice are probably not fully accurate.
Although SF analysis is relatively cheap, effective, simple and reliable, SF analysis is one of the least used tests in rheumatology w14x. According to some authors, the reason is that too few laboratories offer the investigation and too few clinicians request it w14x. It has also been proposed to abandon routine SF analysis w15x, on the basis that SF analysis for cells anduor crystals does not aid diagnosis or management in patients with already established rheumatological diagnoses, while constituting an additional cost. Thus, the use of reagent strips could be considered an attractive alternative.
Our study has several limitations. First, our patients represent the recruitment of a tertiary care hospital and we cannot exclude that the results could be different in another setting with a different prevalence of inflammatory SF. Secondly, we did not assess the visual appearance of the SF. Visual appearance could be used alone or in combination with dipsticks as a screening procedure to distinguish inflammatory and non-inflammatory SF.
The best way to distinguish inflammatory and noninflammatory SF remains the laboratory WBC count. However, when a laboratory is not available, particularly in patients with previously established diagnoses, the use of reagent strips could be considered a useful alternative that can be carried out quickly enough to guide initial management. Further studies are needed to assess the performance of such strips in other settings, particularly primary cases, taking into account both the differences in recruited patients and the different laboratories involved in daily practice. Patients with monoarthritis in whom no diagnosis could be made were included in this category.
